Burgundy Asset Management Ltd. Reduces Stock Position in CME Group Inc. $CME

Burgundy Asset Management Ltd. cut its position in CME Group Inc. (NASDAQ:CME) by 1.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 575,337 shares of the financial services provider’s stock after selling 11,427 shares during the period. CME Group makes up 1.4% of Burgundy Asset Management Ltd.’s holdings, making the stock its 26th largest position. Burgundy Asset Management Ltd.’s holdings in CME Group were worth $153,333,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Amundi raised its position in CME Group by 24.0% during the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock worth $548,150,000 after buying an additional 385,225 shares during the last quarter. Truist Financial Corp increased its stake in shares of CME Group by 8.9% in the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock worth $19,106,000 after acquiring an additional 5,773 shares during the period. Alley Investment Management Company LLC raised its holdings in shares of CME Group by 86.0% during the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after purchasing an additional 13,512 shares during the last quarter. Elevate Capital Advisors LLC lifted its position in CME Group by 85.2% during the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after purchasing an additional 3,919 shares during the period. Finally, Victory Financial Group LLC boosted its holdings in CME Group by 310.2% in the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock valued at $839,000 after purchasing an additional 2,302 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Performance

Shares of CME stock opened at $320.00 on Thursday. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12-month low of $248.53 and a 12-month high of $329.16. The business’s 50 day moving average is $290.56 and its two-hundred day moving average is $277.01. The company has a market capitalization of $115.39 billion, a P/E ratio of 28.67, a P/E/G ratio of 3.78 and a beta of 0.24.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the business earned $2.52 earnings per share. The business’s revenue was up 8.1% compared to the same quarter last year. Analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be given a dividend of $1.30 per share. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date is Tuesday, March 10th. CME Group’s dividend payout ratio (DPR) is currently 44.80%.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Jefferies raised its price target to $356, backing upside as volumes and margins remain healthy. Jefferies Boosts Price Target
• Positive Sentiment: CME reported record monthly average daily volume (ADV) of 37.6M contracts in February (up 14% YoY) and new open interest/ADV records in its Dairy franchise — positive for fee revenue and long-term growth. Monthly ADV Record Dairy OI Record
• Positive Sentiment: Crypto tailwinds — technical signals for Bitcoin and an unfilled CME futures gap could lift crypto derivatives volumes, which helps CME’s products mix. Bitcoin Signals
• Neutral Sentiment: Argus reaffirmed a “hold” rating — not a downgrade but not strongly bullish either. Argus Hold Reaffirmed
• Neutral Sentiment: Short-interest data in early March appears inconsistent/erroneous (reported as 0 shares / NaN increases) and is not providing a clear signal. (Data noise — treat with caution.)
• Neutral Sentiment: Macro note: CME FedWatch signals show a higher probability the Fed will pause, which can reduce interest-rate-driven trading volatility (mixed impact on volumes). Fed More Likely To Stay Pat
• Negative Sentiment: CME rebuffed traders seeking compensation after a trading outage that affected settlement — a reputational and legal risk that could spook some clients and lead to vendor/trader friction. CME Rebuffs Traders
• Negative Sentiment: After the analyst upgrade and a new 1‑year high, near-term profit-taking and rotation have likely pushed the share price down despite the positive fundamental flow data (typical short-term market reaction).

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Raymond James Financial cut their price target on CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. Jefferies Financial Group raised their target price on CME Group from $302.00 to $356.00 and gave the stock a “buy” rating in a report on Monday. Barclays lifted their price target on CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. Royal Bank Of Canada upped their price objective on CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 5th. Finally, TD Cowen raised their price objective on shares of CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $302.71.

Insider Buying and Selling at CME Group

In related news, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the transaction, the chief executive officer owned 65,804 shares in the company, valued at $17,737,468.20. This represents a 27.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Bryan T. Durkin sold 4,200 shares of CME Group stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the completion of the sale, the director owned 43,007 shares in the company, valued at approximately $13,317,117.55. The trade was a 8.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 30,248 shares of company stock valued at $8,355,450. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.